Caplacizumab
Aus coViki
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „Caplacizumab is a therapeutic monoclonam antibody which interferes with bindung of platelets to extralong vWF multimers. It is first-line acute treatment optio…“) |
K |
||
| (Eine dazwischenliegende Version von einem Benutzer wird nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
| − | Caplacizumab is a therapeutic | + | {{up|PHA Biologicals}} |
| + | |||
| + | Caplacizumab is a therapeutic monoclonal antibody which interferes with binding of platelets to extralong vWF multimers. It is first-line acute treatment option of TTP thrombotic thrombocytopenic purpura. I heard a talk at dgfn2020 and decided to aks the open question, might it be useful for covid19. 3 min answer :)))) | ||
Nothing at pubmed, some at pmc by full-text cooccurence of phrases, e.g. | Nothing at pubmed, some at pmc by full-text cooccurence of phrases, e.g. | ||
{{ttp|p=32454092|t=2020. Microvascular thrombosis: experimental and clinical implications |pdf=|usr=}} | {{ttp|p=32454092|t=2020. Microvascular thrombosis: experimental and clinical implications |pdf=|usr=}} | ||
Aktuelle Version vom 18. Januar 2021, 20:49 Uhr
| PHA Biologicals |
Caplacizumab is a therapeutic monoclonal antibody which interferes with binding of platelets to extralong vWF multimers. It is first-line acute treatment option of TTP thrombotic thrombocytopenic purpura. I heard a talk at dgfn2020 and decided to aks the open question, might it be useful for covid19. 3 min answer :))))
Nothing at pubmed, some at pmc by full-text cooccurence of phrases, e.g.
| 32454092 2020. Microvascular thrombosis: experimental and clinical implications |
